Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 2521 AL 2535

Deep brain stimulation effects on memory

Laxton AW, Sankar T, Lozano AM, Hamani C.

J Neurosurg Sci. 2012 Dec;56(4):341-4.

Role of metabotropic glutamate receptors in the mechanisms of experimental parkinsonism development

Bashkatova VG, Sudakov SK.

Bull Exp Biol Med. 2012 Sep;153(5):655-7. doi: 10.1007/s10517-012-1790-9.

Peripheral stimulation in treating Parkinson's disease: Is it a realistic idea or a romantic whimsicality?

Asakawa T, Fang H, Hong Z, Sugiyama K, Nozaki T, Namba H.

Intractable Rare Dis Res. 2012 Nov;1(4):144-50. doi: 10.5582/irdr.2012.v1.4.144.

Gaucher disease: insights from a rare Mendelian disorder

Sidransky E.

Discov Med. 2012 Oct;14(77):273-81.

Cueing for freezing of gait: a need for 3-dimensional cues?

Snijders AH, Jeene P, Nijkrake MJ, Abdo WF, Bloem BR.

Neurologist. 2012 Nov;18(6):404-5. doi: 10.1097/NRL.0b013e31826a99d1.

Comparison of dysphagia before and after deep brain stimulation in Parkinson's disease

Silbergleit AK, LeWitt P, Junn F, Schultz LR, Collins D, Beardsley T, Hubert M, Trosch R, Schwalb JM.

Mov Disord. 2012 Dec;27(14):1763-8. doi: 10.1002/mds.25259. Epub 2012 Oct 31.

Overcoming obstacles in Parkinson's disease

Sherer TB, Chowdhury S, Peabody K, Brooks DW.

Mov Disord. 2012 Nov;27(13):1606-11. doi: 10.1002/mds.25260. Epub 2012 Oct 31.

Sleep and Parkinson's disease: a review of case-control polysomnography studies

Peeraully T, Yong MH, Chokroverty S, Tan EK.

Mov Disord. 2012 Dec;27(14):1729-37. doi: 10.1002/mds.25197. Epub 2012 Oct 31.

Interleaving deep brain stimulation for a patient with both Parkinson's disease and essential tremor

Baumann CR, Imbach LL, Baumann-Vogel H, Uhl M, Sarnthein J, Sürücü O.

Mov Disord. 2012 Nov;27(13):1700-1. doi: 10.1002/mds.25221. Epub 2012 Oct 31.

Treatment of multiple system atrophy using intravenous immunoglobulin

Novak P, Williams A, Ravin P, Zurkiya O, Abduljalil A, Novak V.

BMC Neurol. 2012 Nov 1;12:131. doi: 10.1186/1471-2377-12-131.

Probable association of tachyarrhythmia with nebulized albuterol in a child with previously subclinical wolff Parkinson white syndrome

Kroesen M, Maseland M, Smal J, Reimer A, van Setten P.

J Pediatr Pharmacol Ther. 2012 Jan;17(1):93-7. doi: 10.5863/1551-6776-17.1.93.

Chromaffin cell transplants: from the lab to the clinic

Ambriz-Tututi M, Monjaraz-Fuentes F, Drucker-Colín R.

Life Sci. 2012 Dec 17;91(25-26):1243-51. doi: 10.1016/j.lfs.2012.10.012. Epub 2012 Oct 30.

Atypical parkinsonism and cerebrotendinous xanthomatosis: report of a family with corticobasal syndrome and a literature review

Rubio-Agusti I, Kojovic M, Edwards MJ, Murphy E, Chandrashekar HS, Lachmann RH, Bhatia KP.

Mov Disord. 2012 Dec;27(14):1769-74. doi: 10.1002/mds.25229. Epub 2012 Nov 2.

A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants

Sharma M, Ioannidis JP, Aasly JO, Annesi G, Brice A, Bertram L, Bozi M, Barcikowska M, Crosiers D, Clarke CE, Facheris MF, Farrer M, Garraux G, Gispert S, Auburger G, Vilariño-Güell C, Hadjigeorgiou GM, Hicks AA, Hattori N, Jeon BS, Jamrozik Z, Krygowska-Wajs A, Lesage S, Lill CM, Lin JJ, Lynch T, Lichtner P, Lang AE, Libioulle C, Murata M, Mok V, Jasinska-Myga B, Mellick GD, Morrison KE, Meitnger T, Zimprich A, Opala G, Pramstaller PP, Pichler I, Park SS, Quattrone A, Rogaeva E, Ross OA, Stefanis L, Stockton JD, Satake W, Silburn PA, Strom TM, Theuns J, Tan EK, Toda T, Tomiyama H, Uitti RJ, Van Broeckhoven C, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Yomono HS, Yueh KC, Zhao Y, Gasser T, Maraganore D, Krüger R; GEOPD consortium.

J Med Genet. 2012 Nov;49(11):721-6. doi: 10.1136/jmedgenet-2012-101155.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias